About CU6
Clarity Pharmaceuticals Ltd (CU6) operates as a clinical stage radiopharmaceutical entity focused on treatment of serious diseases. The organisation develops TCTs based on the SAR Technology Platform for treatment of cancers.
Find out what a historical investment in Clarity Pharmaceuticals would be worth today using our CU6 stock calculator.
Market Capitalisation
$731.24M
Price-earnings ratio
-6.73
Dividend yield
-
High today
$1.96
Low today
$1.85
Open price
$1.95
52-week high
$5.87
52-week low
$1.80
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CU6
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in CU6 on Stake
- Buy CU6 from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
CU6 related stocks